For investors seeking momentum, Barron's 400 ETF (BFOR - Free Report) is probably on radar now. The fund just hit a 52-week high, which is up roughly 21.6% from its 52-week low price of $36.66/share..
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
BFOR in Focus
BFOR focuses on high performing equity securities of U.S. companies. The underlying index of the fund normally comprises 400 stocks, which are selected on the basis of their fundamental strength in the field of growth, valuation, profitability and cash flow.
BFOR charges investors 65 basis points a year in fees and has top holdings in Denbury Resources, Medifast and Trade Desk (see Total Market (U.S.) ETFs here).
Why the Move?
With uncertainty prevailing in the market due to trade war tensions and rising rate worries, a look at a quality ETF like BFOR seems warranted at the current level.
More Gains Ahead?
The fund has a positive weighted alpha of 16.70. A positive weighted alpha hints at more gains.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>